PMID: 9537578Apr 16, 1998Paper

Reproductive factors and breast cancer in New Zealand

International Journal of Cancer. Journal International Du Cancer
M McCredieS Williams

Abstract

A national population-based case-control study was used to assess the influence on breast cancer risk of reproductive factors and the possibility of an interaction with age at diagnosis. A total of 891 women aged 25 to 54 with a first diagnosis of breast cancer, and 1864 control subjects, randomly selected from the electoral rolls, were interviewed. There was a declining risk of breast cancer with increasing age at menarche (p = 0.06), the strongest effect being seen in women aged less than 40. Parous women had a 27% lower risk of breast cancer than nulliparous women, a reduced risk being evident in all but the youngest age group. A falling risk of breast cancer with rising parity was clear only in women diagnosed when aged at least 45 years. Breast cancer risk tended to fall amongst parous women with increasing duration of breastfeeding (p = 0.14); the association was most apparent in the youngest women, while those over 40 years at diagnosis showed no clear negative trend. There was no association of breast cancer risk with age at first full-term pregnancy, time since last full-term pregnancy, abortion (spontaneous or induced), abortion before first full-term pregnancy, or ability to conceive, and there was no trend in risk w...Continue Reading

References

Jul 30, 1991·International Journal of Cancer. Journal International Du Cancer·M J SneydD C Skegg
Oct 15, 1990·International Journal of Cancer. Journal International Du Cancer·M EwertzH Tulinius
Mar 15, 1990·International Journal of Cancer. Journal International Du Cancer·E NegriN E Day
Sep 15, 1990·International Journal of Cancer. Journal International Du Cancer·C PaulG F Spears
Jun 15, 1989·International Journal of Cancer. Journal International Du Cancer·D A Leon
Oct 29, 1988·BMJ : British Medical Journal·P BruzziM R Del Turco
Dec 1, 1988·American Journal of Epidemiology·E NegriM Rosselli del Turco
Dec 1, 1986·International Journal of Epidemiology·T G HislopL Kan
Jan 15, 1986·International Journal of Cancer. Journal International Du Cancer·D R PathakR J Lipnick
Jan 1, 1982·Breast Cancer Research and Treatment·J RussoI H Russo
Nov 1, 1982·American Journal of Epidemiology·D T Janerich, M B Hoff
Jan 1, 1983·American Journal of Epidemiology·S P HelmrichM Levy
Aug 9, 1980·British Medical Journal·K L WoodsJ M Morrison
May 1, 1995·Cancer Causes & Control : CCC·L A BrintonJ R Daling
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C HsiehW C Willett
Apr 15, 1994·American Journal of Epidemiology·B RosnerW C Willett
Dec 1, 1993·American Journal of Epidemiology·G Maldonado, S Greenland
Jan 13, 1994·The New England Journal of Medicine·P A NewcombB MacMahon
Dec 15, 1993·American Journal of Epidemiology·C P YangJ R Daling
Jan 1, 1993·Epidemiologic Reviews·D J Hunter, W C Willett
Jan 1, 1993·Epidemiologic Reviews·J L KelseyE M John
Nov 1, 1995·Cancer Causes & Control : CCC·C PaulG F Spears
May 1, 1996·British Journal of Cancer·H A WeissC A Swanson
Jul 1, 1996·Cancer Causes & Control : CCC·G AlbrektsenG Kvåle
Sep 1, 1996·Cancer Causes & Control : CCC·D C SkeggS M Williams
Jan 9, 1997·The New England Journal of Medicine·M MelbyeP K Andersen
Jan 1, 1997·Cancer Causes & Control : CCC·P A WingoS L Parker
Jan 1, 1997·British Journal of Cancer·S M EngerL Bernstein
Dec 6, 1997·International Journal of Cancer. Journal International Du Cancer·M McCredieS Williams

❮ Previous
Next ❯

Citations

Dec 4, 2008·Journal of Women's Health·Li Yang, Kathryn H Jacobsen
Jun 1, 2002·Breast Cancer Research and Treatment·F Clavel-Chapelon, M Gerber
Oct 30, 2004·Annals of Human Biology·Ghausia Masood Gilani, Shahid Kamal
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Laufey TryggvadóttirTrausti Sigurvinsson
Nov 11, 2010·International Journal of Cancer. Journal International Du Cancer·Reza GhiasvandSeyed Hamid Reza Tabatabaee
Mar 10, 2001·Pediatric Clinics of North America·M H Labbok
Oct 24, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Mojtaba SepandiAbdolrasoul Talei
Feb 18, 2004·The Breast : Official Journal of the European Society of Mastology·C RobertsonP Boyle
Jan 15, 2005·Cancer Science·Koji TamakoshiUNKNOWN JACC Study Group
May 28, 2013·Asia-Pacific Journal of Public Health·Thunyarat AnothaisintaweeAmmarin Thakkinstian
Apr 20, 2004·International Journal of Cancer. Journal International Du Cancer·Timothy L Lash, Aliza K Fink
Aug 14, 2013·Journal of Clinical Nursing·Emilio González-JiménezJudit Álvarez
May 3, 2003·Breast Cancer Research and Treatment·Mona OkashaGeorge Davey Smith
Sep 12, 2002·Breast Cancer Research : BCR·Mandana EbrahimiAli Montazeri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
P A NewcombW C Willett
JAMA : the Journal of the American Medical Association
M GammonM B Terry
International Journal of Cancer. Journal International Du Cancer
M GammonJ E Bertin
International Journal of Cancer. Journal International Du Cancer
Gunnar ErlandssonA Ekbom
© 2022 Meta ULC. All rights reserved